Epirubicin and antineoplasticsNo response: case report

被引：0

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1965卷 / 1期

关键词：

D O I：

10.1007/s40278-023-43168-5

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：200 / 200

相关论文

共 50 条

[31] AntineoplasticsNo response: 3 case reports [J].

Reactions Weekly, 2023, 1954 (1) :63-63

[32] AntineoplasticsNo therapeutic response in pulmonary invasive mucinous adenocarcinoma: case report [J].

Reactions Weekly, 2020, 1814 (1) :64-64

[33] Capecitabine/epirubicin/oxaliplatinNo response: case report [J].

Reactions Weekly, 2022, 1898 (1) :123-123

[34] AntineoplasticsNo therapeutic response: 4 case reports [J].

Reactions Weekly, 2022, 1908 (1) :72-72

[35] AntineoplasticsNo therapeutic response: 6 case reports [J].

Reactions Weekly, 2020, 1833 (1) :55-55

[36] AntineoplasticsNo therapeutic response: 4 case reports [J].

Reactions Weekly, 2023, 1967 (1) :53-53

[37] AntineoplasticsNo therapeutic response: 5 case reports [J].

Reactions Weekly, 2023, 1941 (1) :56-56

[38] AntineoplasticsNo response and various toxicities: 3 case reports [J].

Reactions Weekly, 2020, 1832 (1) :48-48

[39] AntineoplasticsNo therapeutic response and neutropenia: 2 case reports [J].

Reactions Weekly, 2022, 1901 (1) :76-76

[40] Epirubicin/ifosfamideNeutropenia: case report [J].

Reactions Weekly, 2015, 1571 (1) :88-88

← 1 2 3 4 5 →